URGN · CIK 0001668243 · operating
UroGen Pharma Ltd. (URGN) is a pharmaceutical preparations company incorporated in Israel, listed on the Nasdaq. With a market capitalization of $890 million, UroGen Pharma Ltd. is a small-cap company. The stock currently trades at $19.02, down 12.35% today, with a 52-week range of $3.42–$30.00. The company trades at a forward P/E of 13.5x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | — | $-3.19 | -298.7% | |
| 2024 | — | $-0.80 | +77.5% | |
| 2023 | — | $-3.55 | +26.2% | |
| 2022 | — | $-4.81 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-03-02 | 0001437749-26-006234 | SEC ↗ |
| 2024-12-31 | 2025-03-10 | 0001437749-25-006842 | SEC ↗ |
| 2023-12-31 | 2024-03-14 | 0001437749-24-007753 | SEC ↗ |
| 2022-12-31 | 2023-03-24 | 0001437749-23-007710 | SEC ↗ |
| 2021-12-31 | 2022-03-21 | 0001437749-22-006778 | SEC ↗ |
| 2020-12-31 | 2021-03-18 | 0001564590-21-014016 | SEC ↗ |
| 2019-12-31 | 2020-03-02 | 0001564590-20-007970 | SEC ↗ |
| 2018-12-31 | 2019-02-28 | 0001564590-19-005323 | SEC ↗ |